Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anti-selectin therapy modifies skeletal muscle ischemia and reperfusion injury.

Anti-selectin therapy modifies skeletal muscle ischemia and reperfusion injury. Shock. 1996 Jun; 5(6):402-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.